Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01954784
Title Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

multiple myeloma

Therapies

Bortezomib + Cyclosporine + Mycophenolate mofetil

Lenalidomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.